Benchtop sequencing has moved beyond the question of how many reads an instrument can generate in a single run. For many biotechnology, pharmaceutical and translational research laboratories, the more important question is what the platform can become as research requirements change. A laboratory may begin with targeted DNA sequencing and later add RNA-seq, whole-exome sequencing,…
Selecting a high-performance liquid chromatography (HPLC) system is not simply a matter of choosing the instrument with the highest pressure rating, the largest autosampler, or the longest list of features. The appropriate system is the one that consistently supports the laboratory’s analytical methods, sample workload, sensitivity requirements, data workflow, quality system, and long-term operating needs….
Choosing an ultra-low temperature freezer is not simply a matter of finding a unit that reaches −80°C. For laboratories, biobanks, biotechnology companies and pharmaceutical organizations, the more important question is whether the freezer can protect the intended materials reliably within the laboratory’s actual operating environment. The right choice depends on several factors: what will be…
Traditional pharmaceutical direct-to-consumer (DTC) marketing was largely built around awareness. Television commercials, magazine advertisements and other mass-media campaigns encouraged patients to “ask your doctor,” but what happened afterward remained largely outside the manufacturer’s or marketer’s visibility. The result was a fragmented journey from awareness to consultation, diagnosis, prescription, fulfillment and follow-up. Modern DTC healthcare platforms…
For decades, pharmaceutical, biotechnology, and medical-device companies built global operations around specialization, scale, and relatively frictionless international trade. Active pharmaceutical ingredients (APIs), key starting materials (KSMs), laboratory inputs, and manufacturing services could be sourced from countries with established capabilities and competitive costs, while contract manufacturers supported production across multiple regions. That model is now being…
Pharmaceutical M&A is entering another important phase as large drugmakers confront a combination of expiring exclusivity, concentrated product revenues and the need to replenish late-stage pipelines. IQVIA estimates that more than $230 billion in biopharma revenue could face loss-of-exclusivity exposure by 2030, with additional exposure expected in the early 2030s. At the same time, large…
The era of enormous, oversubscribed biotech rounds based largely on promising preclinical science has given way to a more demanding funding environment. The latest biotech venture capital trends show investors placing greater weight on clinical evidence, capital efficiency, regulatory execution and credible routes to liquidity. In the first half of 2026, biopharma venture funding reached…
Telemedicine has moved well beyond the emergency model adopted during the COVID-19 pandemic. What began in many organizations as a rapid deployment of video consultations is becoming a permanent component of healthcare delivery, supporting outpatient care, specialist access, chronic disease management, and hospital-at-home models. Modern telemedicine infrastructure is much more than a video-conferencing application. It…
Electronic Health Records (EHRs) have become critical infrastructure for modern healthcare, connecting clinicians, laboratories, pharmacies, administrators, patients, and third-party applications through increasingly complex digital ecosystems. That connectivity also makes healthcare organizations attractive targets for ransomware groups, credential theft, phishing campaigns, and other cyberattacks. The consequences of an EHR compromise extend far beyond financial losses or…
For many patients, accessing healthcare still begins with frustration: confusing phone trees, repetitive forms, separate logins and disconnected departments that seem to operate independently. Each additional step creates another opportunity for a patient to abandon the process or postpone care. A digital front door (DFD) addresses this problem by treating digital access as an interconnected…